Thrombotic risk factors in patients undergoing chemotherapy via peripherally inserted central catheter

Journal of International Medical Research

Volumn 42, Issue 3, 2014, Pages 863-869

  Shi, Yulan ^a   Wen, Li ^a   Zhou, Yanyan ^a   Tao, Sifeng ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

chemotherapy; Peripherally inserted central catheter; risk factors; thrombosis

Indexed keywords

HEMOGLOBIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CHEMOTHERAPY; COLOR ULTRASOUND FLOWMETRY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; INCIDENCE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE COUNT; VENOUS CIRCULATION; AGE; BODY MASS; CATHETERIZATION; CHINA; COMPLICATION; INDWELLING CATHETER; LEUKOCYTE COUNT; MIDDLE AGED; NEOPLASMS; PATHOLOGY; STATISTICAL MODEL; VENOUS THROMBOSIS;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; BODY MASS INDEX; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CHINA; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOSIS;

EID: 84904719575     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060514527061     Document Type: Article

References (43)

1. Khorana AA,Francis CW,Culakova E, et al.Thromboembolism in hospitalized neutropenic cancer patients.J Clin Oncol. 2006;24:484-490.
2. Khorana AA,Francis CW,Culakova E, et al.Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.Cancer. 2007;110:2339-2346.
3. Walker AJ,Card TR,West J, et al.Incidence of venous thromboembolism in patients with cancer - A cohort study using linked United Kingdom databases.Eur J Cancer. 2013;49:1404-13.
4. Agnelli G,George DJ,Kakkar AK, et al.Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.N Engl J Med. 2012;366:601-609.
5. Kyrle PA,Eichinger S.Deep vein thrombosis.Lancet. 2005;365:1163-1174.
6. Abdullah BJ,Mohammad N,Sangkar JV, et al.Incidence of upper limb venous thrombosis associated with peripherally inserted central catheters (PICC).Br J Radiol. 2005;78:596-600.
7. Turcotte S,Dubé S,Beauchamp G.Peripherally inserted central venous catheters are not superior to central venous catheters in the acute care of surgical patients on the ward.World J Surg. 2006;30:1605-1619.
8. Heit JA.Predicting the risk of venous thromboembolism recurrence.Am J Hematol. 2012;87:S63-S67.
9. Khorana AA,Kuderer NM,Culakova E, et al.Development and validation of a predictive model for chemotherapy-associated thrombosis.Blood. 2008;111:4902-4907.
10. Shiwaku K,Anuurad E,Enkhmaa B, et al.Appropriate BMI for Asian populations.Lancet. 2004;363 (9414): 1077-1077.
11. Caprini JA,Arcelus JI,Reyna JJ.Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease.Semin Hematol. 2001;38:12-19.
12. Davison SP,Venturi ML,Attinger CE, et al.Prevention of venous thromboembolism in the plastic surgery patient.Plast Reconstr Surg. 2004;114:43E-51E.
13. Wells PS,Anderson DR,Bormanis J, et al.Application of a diagnostic clinical model for the management of hospitalized patients with suspected deep-vein thrombosis.Thromb Haemost. 1999;81:493-497.
14. Yale SH,Medlin SC,Liang H, et al.Risk assessment model for venothromboembolism in post-hospitalized patients.Int Angiol. 2005;24:250-254.
15. Mommertz G,Sigala F,Glowka TR, et al.Differences of venous thromboembolic risks in vascular general and trauma surgery patients.J Cardiovasc Surg (Torino). 2007;48:727-733.
16. Caprini JA.Thrombosis risk assessment as a guide to quality patient care.Dis Mon. 2005;51:70-78.
17. Grotta JC.Cerebral venous thrombosis - a new diagnosis in travel medicine.J Travel Med. 1996;3:137-137.
18. Lensing AW,Prandoni P,Brandjes D, et al.Detection of deep-vein thrombosis by real-time B-mode ultrasonography.N Engl J Med. 1989;320:342-345.
19. Quintavalla R,Larini P,Miselli A, et al.Duplex ultrasound diagnosis of symptomatic proximal deep vein thrombosis of lower limbs.Eur J Radiol. 1992;15:32-36.
20. Oger E,Leroyer C,Le Moigne E, et al.The value of a risk factor analysis in clinically suspected deep venous thrombosis.Respiration. 1997;64:326-330.
21. White RH,Henderson MC.Risk factors for venous thromboembolism after total hip and knee replacement surgery.Curr Opin Pulm Med. 2002;8:365-371.
22. Abdollahi M,Cushman M,Rosendaal FR.Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use.Thromb Haemost. 2003;89:493-498.
23. Stein PD,Beemath A,Olson RE.Obesity as a risk factor in venous thromboembolism.Am J Med. 2005;118:978-980.
24. Darvall KA,Sam RC,Silverman SH, et al.Obesity and thrombosis.Eur J Vasc Endovasc Surg. 2007;33:223-233.
25. Zhao W,Zhang J,Lu Y, et al.The vasorelaxant effect of H2S as a novel endogenous K(ATP) channel opener.EMBO J. 2001;20:6008-6016.
26. Biró E,Sturk-Maquelin KN,Vogel GM, et al.Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner.J Thromb Haemost. 2003;1:2561-2568.
27. Diamant M,Tushuizen ME,Sturk A, et al.Cellular microparticles: new players in the field of vascular disease?.Eur J Clin Invest. 2004;34:392-401.
28. Rosendaal FR,Helmerhorst FM,Vandenbroucke JP.Female hormones and thrombosis.Arterioscler Thromb Vasc Biol. 2002;22:201-210.
29. Schmitt M,Kuhn W,Harbeck N, et al.Thrombophilic state in breast cancer.Semin Thromb Hemost. 1999;25:157-166.
30. Nemerson Y.Tissue factor: then and now.Thromb Haemost. 1995;74:180-184.
31. Rauch U,Nemerson Y.Circulating tissue factor and thrombosis.Curr Opin Hematol. 2000;7:273-277.
32. Sambola A,Osende J,Hathcock J, et al.Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity.Circulation. 2003;107:973-977.
33. Kato K,Elsayed YA,Namoto M, et al.Enhanced expression of tissue factor activity in the atherosclerotic aortas of cholesterol-fed rabbits.Thromb Res. 1996;82:335-347.
34. Storti S,Crucitti P,Cina G.Risk factors and prevention of venous thromboembolism.Rays. 1996;21:439-460.
35. Anderson FA Jr,Spencer FA.Risk factors for venous thromboembolism.Circulation. 2003;107:I9-I16.
36. Ortel TL.Acquired thrombotic risk factors in the critical care setting.Crit Care Med. 2010;38:S43-S50.
37. Prandoni P.Acquired risk factor for venous thromboembolism in medical patients.Hematology Am Soc Hematol Educ Program. 2005;:458-461.
38. Ageno W,Becattini C,Brighton T, et al.Cardiovascular risk factors and venous thromboembolism: a meta-analysis.Circulation. 2008;117:93-102.
39. Ridker PM,Hennekens CH,Lindpaintner K, et al.Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.N Engl J Med. 1995;332:912-917.
40. Eichinger S,Weltermann A,Mannhalter C, et al.The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.Arch Intern Med. 2002;162:2357-2360.
41. Corral J,Zuazu-Jausoro L,Rivera J, et al.Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family.Br J Haematology. 1999;105:560-563.
42. Djordjević V,Rakićević L,Radojković D.An overview of genetic risk factors in thrombophilia.Srp Arh Celok Lek. 2010;138:79-81.
43. Geerts WH,Heit JA,Clagett GP, et al.Prevention of venous thromboembolism.Chest. 2001;119:132S-175S.